Half,Clothing, Shoes Jewelry , Women , Jewelry,.925,/lengthen560575.html,Weave',Silver,Sterling,NOVICA,petresort.jp,Earrings,$27,'Bali,Hoop $27 NOVICA .925 Sterling Silver Half Hoop Earrings 'Bali Weave' Clothing, Shoes Jewelry Women Jewelry $27 NOVICA .925 Sterling Silver Half Hoop Earrings 'Bali Weave' Clothing, Shoes Jewelry Women Jewelry NOVICA .925 Sterling Silver Half Earrings Max 71% OFF Weave' 'Bali Hoop Half,Clothing, Shoes Jewelry , Women , Jewelry,.925,/lengthen560575.html,Weave',Silver,Sterling,NOVICA,petresort.jp,Earrings,$27,'Bali,Hoop NOVICA .925 Sterling Silver Half Earrings Max 71% OFF Weave' 'Bali Hoop

NOVICA .925 Sterling Silver Half Earrings Max 71% OFF Weave' 'Bali Ranking TOP7 Hoop

NOVICA .925 Sterling Silver Half Hoop Earrings 'Bali Weave'

$27

NOVICA .925 Sterling Silver Half Hoop Earrings 'Bali Weave'

|||

Product description

NOVICA, in association with National Geographic, works together with talented artisan designers around the world to produce stunning, keepsake treasures. Our mantra is to spread global happiness, so rest assured - we’ll do everything we possibly can to ensure you’re a happy customer.

About this item: Sterling silver is crafted into intricate woven designs, curling below the ears with a sensual allure. Designed by Balinese artisan Cahya Krisna, these half-hoop earrings feature delicate openwork with a striking combination of finishes.

About our Artist: 'I'm Cahya Krisna and I was born in Bali in 1997. My friends say I'm passionate and diligent. I am very grateful to have been born and raised in a town full of creative people. Many artisans in my hometown have worked with silver and gold for generations. My dad graduated from high school and my mom only finished middle school, but both are known as brilliant silversmiths. They have been crafting jewelry since they were young and taught me. I began working with them when I was 15. Then, I began helping my uncle design jewelry as well. The challenge of my art is making new designs and crafting them into quality jewelry.'...

NOVICA .925 Sterling Silver Half Hoop Earrings 'Bali Weave'

CURRENT ISSUE
November, 2021

No. 106 (11)

2020 Impact Factor: 9.941 Submission > Acceptance: 52 days
ARTICLES IN THREE SENTENCES
Article

Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma

Transducin β-like protein 1 (TBL1) plays a crucial role in controlling the stability of regulatory proteins involved in cell proliferation and autophagy induction. This study revealed that, unlike normal B cells, diffuse large B-cell lymphoma cells express abundant levels of TBL1 and its overexpression correlates with poor clinical outcome. Targeting TBL1 promoted lymphoma cell death in vitro and in vivo. These results provide the rationale for targeting TBL1 as a novel therapeutic strategy in diffuse large B-cell lymphoma.

Youssef Youssef et al.

Article

Targeting shear gradient activated von Willebrand factor by the novel single-chain antibody A1 reduces occlusive thrombus formation in vitro

The authors of this study developed a single-chain antibody that targets a shear gradient-specific conformation of von Willebrnad factor (VWF). In vitro studies showed that this antibody specifically reduces VWF-GPIbα binding and thrombus formation at sites of shear rate gradients but does not block platelet deposition and aggregation under constant shear rate. This characteristic places the antibody in a new class of antiplatelet therapy for selective blockade of pathological thrombus formation while maintaining normal hemostasis.

Thomas Hoefer et al.

Case Report

Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia

A 26-year-old female developed vaccine-induced immune thrombotic thrombocytopenia (VITT) with cerebral venous thrombosis and bi-hemispheric hemorrhage following the first dose of the ChAdOx1 nCoV-19 vaccine. The treatment protocol, based on intravenous immunoglobulins, dexamethasone and argatroban was successful with almost complete clinical, laboratory and radiological response. This experience supports the application of an early and multidisciplinary therapeutic approach in cases of VITT, with the possibility of avoiding deaths and obtain a resolution of the syndrome.

Sara Bonato et al.

Letter

Allogeneic hematopoietic stem cell transplantation from non-sibling 10/10 HLA-matched related donors: a single-center experience

This retrospective study compared the outcome of allogeneic hematopoietic stem cell transplantation (HSCT) in 23 patients with hematologic malignancies transplanted from non-sibling fully matched related donors to that of patients who underwent conventional haplo-HSCT. Subjects transplanted from fully matched related donors showed trends to a higher relapse rate and lower cumulative incidence of grade II-IV acute graft-versus-host disease, but overall survival was similar. The authors concluded that individualized adjustment of the immunosuppressive treatment is reasonable for this category of patients.

Yaoyao Shen et al.

TAKE ADVANTAGE FROM HAEMATOLOGICA